Stockreport

A Look At Cybin (HELP) Valuation After Positive Phase 2 HLP004 Anxiety Data [Yahoo! Finance]

Cybin Inc.  (HELP) 
PDF Cybin (HELP) is back in focus after Helus Pharma reported Phase 2 topline data for HLP004 in generalized anxiety disorder, showing clinically meaningful symptom reducti [Read more]